Antihypertensive Peptides from Milk Proteins
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Dietary proteins possess a wide range of nutritional and functional properties. They are used as a source of energy and amino acids, which are needed for growth and development. Many dietary proteins, especially milk proteins, contain physiologically active peptides encrypted in the protein sequence. These peptides may be released during gastrointestinal digestion or food processing and once liberated, cause different physiological functions. Milk-derived bioactive peptides are shown to have antihypertensive, antimicrobial, immunomodulatory, antioxidative and mineral-binding properties. During the fermentation of milk with certain lactobacilli, two interesting tripeptides Ile-Pro-Pro and Val-Pro-Pro are released from casein to the final product. These lactotripeptides have attenuated the development of hypertension in several animal models and lowered blood pressure in clinical studies. They inhibit ACE in vitro at micromolar concentrations, protect endothelial function in vitro and reduce arterial stiffness in humans. Thus, milk as a traditional food product can after certain processing serve as a functional food and carry specific health-promoting effects, providing an option to control blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Effects of Whey Peptides on Cardiovascular Disease Risk Factors
Pins, J. J., & Keenan, J. M. (2006) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05667.x · Cited by 71
RetractedA Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
Appel, L. J., Sacks, F. M., Carey, V. J., Obarzanek, E., Swain, J. F., Miller, E. R., Conlin, P. R., Erlinger, T. P., Rosner, B. A., Laranjo, N. M., et al. (2005) · JAMA · doi:10.1001/jama.294.19.2455 · Cited by 1,170
Dairy Consumption, Obesity, and the Insulin Resistance Syndrome in Young Adults: The CARDIA Study
Pereira, M. A., Jacobs, Jr., Van Horn, L., Slattery, M. L., Kartashov, A. I., & Ludwig, D. S. (2002) · JAMA · doi:10.1001/jama.287.16.2081 · Cited by 1,102
Peptidases and amino acid catabolism in lactic acid bacteria
Christensen, J. E., Dudley, E. G., Pederson, J. A., & Steele, J. L. (1999) · Antonie van Leeuwenhoek · doi:10.1023/a:1002001919720 · Cited by 630 · cited 1×
“In the fermentation process of milk, bioactive peptides can be generated by dairy starter cultures, which show high proteolytic activity [34].”
BackgroundYamamoto, N., Akino, A., & Takano, T. (1994) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(94)77026-0 · Cited by 418 · cited 1×
“helveticus CP790 and milk fermented with the same bacteria [46].”
BackgroundWang, L., Manson, J. E., Buring, J. E., Lee, I.-M., & Sesso, H. D. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.107821 · Cited by 359 · cited 1×
“older (≥45 years) US women without baseline hypertension were followed for 10 years, found that intake of low-fat dairy products was inversely associated with risk of hypertension [9].”
BackgroundBioactive peptides and lactic fermentations.
FITZGERALD, R. J., & MURRAY, B. A. (2006) · International Journal of Dairy Technology · doi:10.1111/j.1471-0307.2006.00250.x · Cited by 355 · cited 1×
“For example, Lactobacillus helveticus and Lactococcus lactis strains have been shown to produce bioactive peptides [36–38].”
BackgroundCasein peptide release and passage to the blood in humans during digestion of milk or yogurt.
Chabance, B., Marteau, P., Rambaud, J. C., Migliore-Samour, D., Boynard, M., Perrotin, P., Guillet, R., Jollès, P., & Fiat, A. M. (1998) · Biochimie · doi:10.1016/s0300-9084(98)80022-9 · Cited by 324
Minervini, F., Algaron, F., Rizzello, C. G., Fox, P. F., Monnet, V., & Gobbetti, M. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.9.5297-5305.2003 · Cited by 270
Cited by
Sánchez, A., & Vázquez, A. (2017) · Food Quality and Safety · doi:10.1093/fqs/fyx006 · Cited by 868
“Two other peptides (Tyr-Pro and Lys-Val-LeuPro-Val-Pro-Gln) purified and characterized from fermented milk also showed ACE inhibitory activity in hypertensive rats (Jäkälä and Vapaatalo, 2010).”
BackgroundInfluentialHealth benefits of fermented foods
Şanlier, N., Gökcen, B. B., & Sezgin, A. C. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1383355 · Cited by 789
Bioactive Peptides: Synthesis, Sources, Applications, and Proposed Mechanisms of Action
Akbarian, M., Khani, A., Eghbalpour, S., & Uversky, V. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031445 · Cited by 612
Daliri, E., Oh, D., & Lee, B. (2017) · Foods · doi:10.3390/foods6050032 · Cited by 539
Antihypertensive peptides: Production, bioavailability and incorporation into foods
Hernández-Ledesma, B., del Mar Contreras, M., & Recio, I. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2010.11.001 · Cited by 511
Metadata
- Authors
- Jäkälä, P., & Vapaatalo, H.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2010-01-19
- Volume
- 3
- Issue
- 1
- Pages
- 251-272
- ISSN
- 1424-8247 (ISSN-L)
- OpenAlex
- W2038463091
- Cited by
- 152
- References
- 12
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antihypertensive Peptides from Milk Proteins. https://app.cochat.ai/papers/10.3390/ph3010251
- The paper
- Jäkälä, P., & Vapaatalo, H. (2010). Antihypertensive Peptides from Milk Proteins. Pharmaceuticals. https://doi.org/10.3390/ph3010251
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.